Inhibition of metastasis of lewis lung carcinoma by a synthetic peptide within growth factor‐like domain of urokinase in the experimental and spontaneous metastasis model
The DOI matches its Crossref record.
Abstract
Four synthetic peptides (residues 20‐30 and 17‐34) within the growth factor‐like domain (GFD) of murine and human urokinase‐type plasminogen activator (uPA) were examined to determine whether they inhibit production of experimental and spontaneous lung metastasis by murine Lewis lung carcinoma (3LL) cells. In an in vivo experimental metastasis assay, which determines mainly the later steps of the metastatic migration process (extravasation from the bloodstream and then growth into pulmonary tumor), none of the peptides introduced by i.v. single co‐injection into syngeneic C57B1/6 mice inhibited pulmonary metastasis, when 3LL cells were pre‐incubated with the peptides followed by i.v. co‐injection of the peptide and cells. In addition, none of the peptides, when injected i.p. daily for 7 days after i.v. tumor cell inoculation, reduced the number of lung tumor colonies. In a second in vivo assay that measures metastasis from a primary tumor (spontaneous metastasis model), multiple i.p. injections of the mouse peptide 17‐34 for 7 days after s.c. tumor cell inoculation significantly inhibited metastatic lung tumor colonization in a dose‐dependent manner, whereas human peptide 17‐34 had no effect. Mouse and human peptide 20‐30 had no effect either. The inhibition of lung metastasis was not due to direct antitumor effects of mouse peptide 17‐34. Our results indicate that occupation of uPA receptors on 3LL cells by the enzymatically inactive mouse peptide 17‐34 or prevention of rebinding of uPA synthesized by tumor cells to their receptor specifically reduced tumor cell invasion and formation of metastasis and that uPA may regulate more efficiently the mechanism involved in the entry of tumor cells into vascular circulation than extravasation during the metastatic process.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The urokinase-type plasminogen activator system in cancer metastasis: A review
Andreasen, P. A., Kjøller, L., Christensen, L., & Duffy, M. J. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19970703)72:1<1::aid-ijc1>3.0.co;2-z · Cited by 1,546
Sidenius, N., & Blasi, F. (2003) · Cancer and Metastasis Reviews · doi:10.1023/a:1023099415940 · Cited by 368
The urokinase plasminogen activator system: a target for anti-cancer therapy
Ulisse, S., Baldini, E., Sorrenti, S., & D'Armiento, M. (2009) · Current Cancer Drug Targets · doi:10.2174/156800909787314002 · Cited by 312
Conese, M., Nykjaer, A., Petersen, C. M., Cremona, O., Pardi, R., Andreasen, P. A., Gliemann, J., Christensen, E. I., & Blasi, F. (1995) · The Journal of cell biology · doi:10.1083/jcb.131.6.1609 · Cited by 191
“with inhibitors of uPA and antagonists of its surface localization (Bergman et al., 1986; Ossowski and Reich, 1983; Hearing et al., 1988; Ossowski, 1988; Ossowski et al., 1991; Quax et al., 1991; Crowley et al., 1993; Kook et al., 1994; Kobayashi et al., 1994 ).”
Su, S.-C., Lin, C.-W., Yang, W.-E., Fan, W.-L., & Yang, S.-F. (2016) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2016.1113260 · Cited by 145
Metadata
- Authors
- Kobayashi, H., Gotoh, J., Fujie, M., Shinohara, H., Moniwa, N., & Terao, T.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 1994-06
- Volume
- 57
- Issue
- 5
- Pages
- 727-733
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2024231269
- Cited by
- 98
- References
- 0
- FWCI
- 3.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Inhibition of metastasis of lewis lung carcinoma by a synthetic peptide within growth factor‐like domain of urokinase in the experimental and spontaneous metastasis model. https://app.cochat.ai/papers/10.1002/ijc.2910570520
- The paper
- Kobayashi, H., Gotoh, J., Fujie, M., Shinohara, H., Moniwa, N., & Terao, T. (1994). Inhibition of metastasis of lewis lung carcinoma by a synthetic peptide within growth factor‐like domain of urokinase in the experimental and spontaneous metastasis model. International Journal of Cancer. https://doi.org/10.1002/ijc.2910570520
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.